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Correlation between serum 25 hydroxy-vitamin D levels and
the worst pain intensity in postherpetic neuralgia
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Universitas Sumatera Utara, Medan, Indonesia
Email: mellaratna.iskandar@gmail.com

Abstract
Background: Postherpetic neuralgia (PHN) is persistent pain in the affected dermatome that occurs more
than three months after the eruption of the herpes zoster has disappeared. Vitamin D has a role in Schwann
cell regeneration and stimulates the release of nerve growth factors.
Methods: Blood sampling was performed to test serum 25(OH)D levels. Patients filled out their worst pain
intensity using the Zoster Brief Pain Inventory questionnaire. The score was reported in Likert score (0-10), 0
indicating no pain and 10 indicating the most severe pain. Spearman correlation test was used, and p <0.05
was considered statistically significant.
Results: The PHN patients were mostly aged ≥60 years (50.0%), female (59.4%), had a deficiency of 25(OH)D
levels (59.4%), and had the worst pain intensity with a score of 9 (40.6%). There were no differences in serum
25(OH)D levels among age groups (p >0.05) and PHN durations (p >0.05). However, there were significant
differences in serum 25(OH)D levels between sex groups (p <0.05). The limitations of this study were that liver
function tests were not carried out, and data on the duration of UV exposure were not taken in this study.
Conclusion: No correlation exists between serum 25(OH)D levels and the worst pain intensity in PHN patients.
Further research with a control group, liver function tests, and the duration of sun exposure data is needed to
conclude the role of 25(OH)D in PHN patients.
Keywords: pain intensity, postherpetic neuralgia, vitamin D

Background
Postherpetic neuralgia (PHN) is a complication of
herpes zoster with a sensation of stabbing pain and
severe allodynia in the affected dermatome that
occurs three months after the onset of herpes
zoster.1 Risk factors of PHN include older age that
contributes to nutritional deficiencies, including
zinc (19%), vitamin C (16%), iron (14%), vitamin D
(12%), vitamin B12 (11%), b carotene (11%),
vitamin E (10%), vitamin A (8%), folic acid (8%),
vitamin B6 (7%), selenium (7%), and copper (3%).2
Based on research conducted by Bartley et al.,3
vitamin D has a role as an anti-inflammatory and
detoxifying agent in nerves. The anti-inflammatory
effect occurs as alpha-melanocyte stimulating
hormone (aMSH) decreases the production of
proinflammatory
cytokines
and
modulates
cytokines, such as IL-10. Vitamin D inhibits the
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synthesis of nitric oxide (NO), which has a role in
neuropathic pain. Vitamin D also increases
glutathione and g-glutamyl peptidase in astrocytes,
which is thought to play a role in scavenging the
reactive oxygen species (ROS). In patients with
PHN, degeneration of Schwann cells and nerve
fibers is found in myelinated and lost cells in the
dorsal root ganglions (DRG). Vitamin D potentially
reduces inflammation of Schwann cells. Vitamin D
also increases nerve growth factor (NGF)
regeneration in keratinocytes and Schwann cells,
triggering Schwann cell regeneration.3
Clinical studies assessing the association between
decreased vitamin D levels and chronic pain are
still limited. However, there is sufficient evidence to
suggest the contribution of vitamin D to the
anatomy and physiology of pain, which influences
the etiology and maintenance of chronic pain status
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and associated comorbidities. Vitamin D also has
a neuroprotective effect that affects the
pathophysiology of chronic pain. Vitamin D
reduces TNF-a, macrophage colony-stimulating
factors (M-CSF), and nitric oxide levels in
astrocytes and microglia. Through inhibition
against M-CSF, vitamin D can block pain
pathways.4 Postherpetic neuralgia is chronic
neuropathic pain, so researchers are interested in
assessing the correlation between vitamin D
deficiency with the worst pain intensity in PHN
patients to know the significance of vitamin D levels
on the pain intensity in PHN patients residing in
tropical countries such as Indonesia.
One of the questionnaires to assess pain intensity,
especially in PHN, is the Zoster Brief Pain
Inventory (ZBPI), which assesses four components
of pain intensity in the last 24 hours, including the
worst pain, the slightest pain, the average pain, and
current pain intensity felt by PHN patients. In this
study, the researchers selected the worst pain
intensity because it has the highest internal validity
(Cronbach’s alpha value 0,77 until 0,90) compared
to the other domains of pain intensity (the slightest
pain, the average pain, and the current pain
intensity).5 Decreased levels of 25(OH)D were
accompanied by increased numbers of the worst
pain intensity.6

Methods
Patients and study design
This was a cross-sectional study conducted at the
Department of Dermatology and Venereology,
Faculty of Medicine, Universitas Sumatera Utara,
Medan. Thirty-two patients were included from July
2019 to December 2019. Data on PHN patients
were collected from the medical records of
Sumatera Utara University Hospital and two public
health centers in Medan. Postherpetic neuralgia
was defined as a neurologic complication of herpes
zoster that causes chronic pain for more than three
months after the rash had disappeared. The
inclusion criteria were patients who had been
diagnosed with PHN from January 2015 to
December 2019, aged over 40 years old
(categorized as 40-44, 45-49, 50-54, 55-59, and ³
60 years), and patients who already signed
informed consent to be involved in this study. The
demographic data included age, sex, and duration
of PHN (measured from three months after the rash
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disappeared until the day of investigation). This
study obtained ethics approvals from the Faculty of
Medicine, Universitas Sumatera Utara, and Adam
Malik Hospital 583/TGL/KEPK FK USU-RSUP
HAM/2019.
Researchers recorded patients’ data, including
age, sex, duration of disease, telephone number,
and home address. Then, the researcher asked
about the patients’ readiness to participate in this
study in their houses. The patients filled out the
worst pain intensity they felt in the last 24 hours on
the ZBPI questionnaire (with permission) in the
Likert score. A score of 0 indicated no pain, and a
score of 10 indicated the worst pain felt by patients.
PHN patients’ blood samples were collected, and
their serum 25 hydroxyvitamin D levels were
measured using the DiaSorin LiaisonÒ instrument.
The serum 25(OH)D levels were reported in
numerical units. The concentration of serum
25(OH)D levels was interpreted as deficient (20
ng/mL), insufficient (21-29 ng/mL), sufficient (30100 ng/mL), and toxic (>100 ng/mL).
Statistical analysis
Spearman correlation test was used to evaluate the
correlation between serum 25(OH)D levels and the
worst pain intensity of postherpetic neuralgia
patients as the data were abnormally distributed
(normality test result). Spearman correlation was
also used to investigate the correlation between
serum 25(OH)D levels and the duration of PHN. An
independent samples t-test was used to determine
the differences in serum 25(OH)D levels based on
sex as the data were normally distributed, and a
one-way ANOVA test was used to determine the
differences in serum 25(OH)D levels among age
groups as the data were normally distributed. A pvalue of <0.05 was considered statistically
significant. The statistical correlation was
categorized into very weak (r 0,0-< 0,2), weak (r =
0,2-0,4), moderate (r = 0,4- <0,6), strong (0,6 <0,8), and very strong (0,8-1,0).

Results
This study included 32 PHN patients. The largest
proportion of patients (50%) was over 60, and the
smallest proportion (3,3%) was in the 50-54 years
age group. The majority of patients were females
(59.4%). The patients’ characteristics are
described in table 1.
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Table 1. Characteristics of PHN patients
Characteristics
Age (years)
40-44
45-49
50-54
55-59
≥ 60
Sex group
Female
Male

n
(N=32)

(%)

5
4
1
6
16

15.6
12.5
3.1
18.8
50.0

19
13

59.4
40.6

The results showed that 19 (59.4%) PHN patients had a deficiency in serum 25(OH)D levels, followed by 9
(28.1%) having insufficiency and 4 (12.5%) having normal levels (table 2).
Table 2. Distribution of serum 25(OH)D levels in PHN patients
Serum 25(OH)D levels
n
(N=32)
19

59.4

Insufficiency

9

28.1

Normal

4

12.5

Toxic

0

0

Deficiency

(%)

Thirteen (40.6%) patients had the worst pain intensity score of 9, whereas 1 (3.1%) and 1 (3.1%) had the worst
pain intensity score of 4 and 6, respectively (table 3).
Table 3. Distribution of worst pain intensity in PHN patients
Worst pain intensity
0
1
2
3
4
5
6
7
8
9
10
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n (%)
0 (0)
0 (0)
0 (0)
3 (9.4)
1 (3.1)
2 (6.3)
1 (3.1)
6 (18.8)
3 (9.4)
13 (40.6)
3 (9.4)

Median (min-max)
8.50 (3-10)
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As shown in table 4, there was no significant correlation between serum 25(OH)D levels and the worst pain
intensity in PHN patients (p > 0.05).
Table 4. Correlation between worst pain intensity and serum 25(OH)D levels
Worst pain intensity
Correlation
coefficient (r)

p

n

-0.070

0.703

32

Serum 25(OH)D
levels

*Spearman correlation test
This study also found that the correlation between serum 25(OH)D levels and the duration of PHN was not
statistically significant (p > 0.05), as described in table 5.
Table 5. Correlation between worst pain intensity and duration of PHN
Duration of PHN

Serum 25(OH)D
levels

Correlation
coefficient (r)

p

n

-0.060

0.744

32

*Spearman correlation test
Most PHN patients in this study were over 60 years old with a mean serum 25(OH)D value of 22.3888 ± 7.618
ng/mL. There were no differences in serum 25(OH)D levels among age groups (p > 0.05), as shown in table
6.
Table 6. Serum 25(OH)D levels in PHN patients, based on age groups
Ages (Years)

Frequency

40-44
5
45-49
4
50-54
1
55-59
6
≥ 60
16
*one-way ANOVA test

Mean ± SD
(ng/mL)
18.880 ± 4.589
18.200 ± 7.411
6.800 ± 0.000
18.367 ± 6.005
22.388 ± 7.618

p
0.213

The mean value of serum 25(OH)D levels in female patients was lower (17.426 ± 5.658 ng/mL) compared to
that in males (23.946 ± 7.614 ng/mL). There were statistically significant differences (p <0.05) in serum
25(OH)D levels between female and male PHN patients (p < 0.05), as shown in table 7.
Table 7. Serum 25(OH)D levels in PHN patients, based on sex groups
Sex groups

Frequency

Female
19
Male
13
*Independent samples t-test
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Mean ± SD
(ng/mL)
17.426 ± 5.658
23.946 ± 7.614

p
0.009
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Discussion
Most PHN patients in this study were in the older age
group, similar to a study by Lu et al.7 which reported
that most (49.8%) of PHN patients were in the 65-74
age group. This finding corresponds to a study by
Chen et al.8 which proposed that increasing age (>
50 years) is a risk factor for developing nutritional
deficiencies, resulting in reduced cellular immunity
that would be prone to virus infection (such as VZV
reactivation). Munoz-Quiles et al.9 reported that
increasing age is associated with the development of
PHN. The study found that compared to the young
age group, PHN was twice as many in the 60-69 age
group, three times higher in the 70-79 age group,
and 3.67 higher in the over 80 age group. In terms
of sex, Munoz-Quiles et al.9 reported that the
incidence of PHN in female patients was two folds
greater than in males. Yu et al.10 also reported that
most PHN patients were female (53.5%), whereas
Lu et al.7 found that most PHN patients were males.
This study showed that most PHN patients had a
deficiency in serum 25(OH)D levels. Chen et al.11
(reported that most PHN patients (79.3%) had
insufficiency in serum 25(OH)D levels with a mean
value of 27.584 ± 7.488 ng/mL, compared to healthy
control (47%) with a normal concentration of serum
25(OH)D levels (30.052 ± 6,988 ng/mL). Chao et
al.12 (also analyzed the serum 25(OH)D levels in
PHN patients and reported that 59.1% had a
deficiency, 33% had an insufficiency, and 8% had
normal serum 25(OH)D levels. Based on pain
intensity experienced by the patients, Schmader et
al.13 stated that the majority of PHN patients (51%)
had severe pain (Likert score 8 to 10), whereas
moderate pain (Likert score 4 to 7) was found in 2030% of patients. The study found a correlation
between pain intensity and increasing interference in
their quality of life. Katz et al.14 reported that the
average score of the worst pain intensity in PHN
patients was 6.74. In this study, most PHN patients
had the worst pain intensity score of 9. Severe pain
intensity felt by PHN patients is probably correlated
with the larger proportion of female PHN patients
who tended to have a low pain threshold. This finding
corresponds to a study by Belfer et al.15 that stated
that females have a low pain threshold, low
sensitization to noxious stimuli, and greater curiosity
about the pain.
This study showed no significant correlation between
serum 25(OH)D levels with the worst pain intensity.
Chen et al.11 reported a significant but weak
correlation (r = -0.329) between spontaneous pain
and serum 25(OH)D levels. Vicira et al.16 reported
that risk factors influencing chronic pain intensity
include older age, female gender, divorce history,

Published by UI Scholars Hub, 2022

low socioeconomic status, low education status,
obesity, and history of alcohol consumption and
smoking. Mellaratna et al.17 stated that the worst pain
intensity had a very strong and significant (p <0.001)
correlation with mood disturbance (r = 0.846) and
working status (r = 0.818). The worst pain intensity
also had a strong and significant (p <0.001)
correlation with general activity (r = 0.673), sleep
disturbance (r = 0.774), social relationship (r =
0.653), and disturbance of enjoyment of life (r =
0.783). Additionally, the worst pain intensity had a
moderate and significant (p <0.001) correlation with
the walking ability (r = 0.475).17
The researchers have not yet found a correlation
between the duration of PHN and serum 25(OH)D
levels. In contrast, Shipton et al.4 found that longterm vitamin D deficiency is associated with
persistent chronic pain. Chao et al.12 proposed that
serum 25(OH)D levels have roles in the nerve injury
mechanism of PHN patients, such as inflammation
reduction in Schwann cells, myelinization,
axogenesis stimulation, and improved immunity to
prevent virus replication in the dorsal root ganglion.
Postherpetic neuralgia incidence involved older age
groups. Twelve percent of elderly patients were
reported to have a vitamin D deficiency that
contributed to decreased immunity, a risk factor of
HZ and PHN.8 Risk factors of vitamin D deficiency
were reduced vitamin D synthesis, minimal UV
exposure, and limited mobility in the older age
group.18 This research showed no differences in
serum 25(OH)D levels among all age groups.
The mean value of serum 25(OH)D levels was lower
in females (22.30 ng/mL) compared to males (24.71
ng/mL), and the difference was statistically
significant. The result of linear regression analysis
from Zadhsir et al.19 indicated that the female sex
was a risk factor for serum 25(OH)D deficiency. Alquaiz et al.20 stated that about 72% of males had a
deficiency in serum 25(OH)D levels, 17.3 % had
insufficiency, and 49,7% had ³ 25 to < 50 ng/mL
serum 25(OH)D levels. This study showed
significant differences in serum 25(OH)D levels
between females and males.
This research had several limitations. The history of
the duration of sunlight exposure was not taken, and
liver function tests were not performed. This study
also did not have a control group. Additionally, this
study had an inadequate sample size, leading to low
statistical power (p= 0,703) to detect a significant
correlation between serum 25(OH)D levels and the
worst pain intensity in PHN patients.
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Conclusion
This study shows no correlation between serum
25(OH)D levels and the worst pain intensity in PHN
patients. Further studies with a control group and
higher statistical power are needed to detect
significant differences between serum 25(OH)D
levels and the worst pain intensity in PHN patients.
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